Blake Borgeson is the founder of Recursion Pharmaceuticals. Recursion Pharmaceuticals has raised $900M in total funding. Latest round: IPO.
Blake Borgeson is a computational biologist, AI strategist, and co-founder of Recursion Pharmaceuticals, an AI-driven drug discovery company. He focuses on using computer vision and cellular imaging to predict drug efficacy for diseases. He is also a Board Member and General Advisor at Recursion and a co-founder and board member of RXRX (Recursion Pharmaceuticals' public entity).
Full founder directory · Investor directory · Company funding database · Fundraising library